Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Gilead Sciences
Masonic Cancer Center, University of Minnesota
Pfizer
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Diego
CRISPR Therapeutics
Universität des Saarlandes
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Medical College of Wisconsin
Thomas Jefferson University
AIDS Malignancy Consortium
Pfizer
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
Columbia University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Novartis
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Novartis
Stanford University
University of Nebraska
University of Nebraska
University of Nebraska
Canadian Cancer Trials Group
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Eastern Cooperative Oncology Group